查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015140

神經科學用內視鏡設備市場：2026-2032年全球市場預測（依產品類型、技術、應用、最終用戶及銷售管道）

Neurology Endoscopy Devices Market by Product Type, Technology, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經科學用內視鏡設備市場價值將達到 2.7241 億美元，到 2026 年將成長至 2.8498 億美元，到 2032 年將達到 3.9213 億美元，複合年成長率為 5.34%。

主要市場統計數據
基準年 2025 2.7241億美元
預計年份：2026年 2.8498億美元
預測年份 2032 3.9213億美元
複合年成長率 (%) 5.34%

簡要概述技術進步和臨床需求如何改變整個醫療保健系統中神經外科內視鏡的應用。

神經科學用內視鏡器材市場正發展成為一個技術先進且臨床敏感度極高的領域，精準醫療設備和微創醫學的概念在此交會融合。影像技術、人體工學設計以及一次性拋棄式產品的進步，使得神經外科醫師能夠進行更多複雜的腦室內和顱底手術，同時降低術中併發症的風險。因此，醫院和專科醫療中心正在調整其臨床流程，將內視鏡手術納入治療方案，即使是以往主要透過開顱手術治療的疾病，也開始採用內視鏡技術。

尖端診斷影像技術與一次性策略的整合正在重新定義設備設計、臨床工作流程以及在臨床環境中的應用。

神經科學用內視鏡領域正經歷一系列變革，從影像能力和一次性使用策略到臨床中心的去中心化，無不體現這些變革。高清4K影像和3D視覺化技術透過為外科醫生提供更清晰的解剖背景和深度訊息，改善了術中決策，從而減少了對輔助暴露和輔助手術的依賴。螢光導引能夠更精確地顯示腫瘤邊界和識別血管，從而拓展了內視鏡手術的臨床適應症。

對新的進口關稅調整如何影響整個醫療設備價值鏈的籌資策略、價格透明度和業務永續營運進行權威評估。

美國於2025年宣布的關稅調整的累積影響，為神經科學用內視鏡設備及其組件的供應鏈帶來了新的複雜性。影響醫療設備組件、精密光學元件和某些電子子系統的關稅調整，迫使製造商重新評估其採購地點、與主要供應商的合約條款以及成本分攤策略。隨著進口關稅推高投入成本，醫療設備製造商正在探索近岸外包和供應商多元化，以在不影響品質或合規性的前提下保護利潤率。

從深刻的細分觀點醫療設備類型、臨床適應症、醫療機構、影像技術和銷售管道與採用促進因素和營運選擇連結起來。

細分市場分析揭示了不同產品類型、應用、終端用戶、技術和銷售管道的細微效能趨勢，這些趨勢對於策略規劃至關重要。產品類型包括軟式內視鏡、硬式內視鏡和影像內視鏡系統。硬式內視鏡可細分為可重複使用型和一次性型，每種類型都存在獨特的臨床和操作方面的權衡。軟式內視鏡系統適用於解剖結構複雜的區域，而影像內視鏡系統則作為先進成像模式的整合中心。

全面的區域分析將揭示報銷方案、法規環境和基礎設施成熟度的差異如何影響設備的部署和商業化路徑。

區域趨勢對神經科學用內視鏡設備的普及、監管路徑和經營模式有顯著影響。在美洲，對先進診斷影像技術的投資以及高病患量三級醫療機構的集中，推動了整合式影像內視鏡系統和先進視覺化輔助設備的快速普及。該地區的健保報銷結構和醫療採購趨勢也傾向於那些能夠顯著提高手術全期效率和病患管理能力的解決方案。

主要企業趨勢與競爭行為：成熟參與者和專業創新者如何推動形象整合、培訓計畫和通路策略。

神經科學用內視鏡設備生態系統的競爭格局呈現出兩極化的特點：既有成熟的外科醫療設備製造商，也有靈活敏捷、專注於創新的創新企業。大型醫療技術公司利用其規模優勢，將成像平台與醫院IT系統整合，投資培訓機構，並提供捆綁式服務契約，從而減輕醫療系統的管理負擔。這些成熟企業通常強調豐富的產品系列、全面的保固服務以及支援多站點部署的全球服務網路。

為製造商和供應商制定可操作的策略重點，以協調技術投資、供應鏈韌性和臨床培訓與永續部署。

產業領導者應優先制定策略議程，使技術投資與臨床療效和供應鏈韌性保持一致。這首先應優先投資於能夠增強術中決策的成像平台，特別是高清 4K 系統和3D可視化技術，同時在臨床適用的情況下整合螢光引導，以提高手術精度。這些技術選擇必須與以結果為導向的證據相結合，以證明其在安全性、效率和患者復原方面具有實際改進。

透過與醫療保健專業人員的訪談、技術整合和資料檢驗相結合的透明研究途徑，可以對醫療設備的性能和採用因素得出可重複的見解。

本分析採用了調查方法結合結構化一手研究、嚴謹的二手資料整合和多面向資料檢驗的方法，以得出平衡且基於證據的結論。一手研究包括對執業神經外科醫生、手術室主管、採購經理和服務技術人員進行詳細訪談，以確定臨床實踐中設備性能、手術流程以及推廣應用障礙等方面的考慮因素。與相關人員的這些對話提供了關於不同醫療機構的臨床偏好、消毒實踐和支持期望的定性見解。

一項權威的綜合分析重點闡述了成像技術進步、一次性策略和供應鏈韌性如何決定採用趨勢和臨床結果。

總而言之，神經科學用內視鏡設備生態系統正進入一個以成像技術快速創新、一次性使用策略的精細化以及新興的供應鏈複雜性為特徵的階段。高解析度4K影像、 3D視覺化和螢光引導等技術進步正在擴大手術能力，並使微創治療複雜顱內疾病成為可能。同時，可重複使用和一次性硬式內視鏡的並存也為醫療系統硬式內視鏡了操作上的選擇，醫療系統必須權衡這些選擇與消毒規範和資本投資規劃之間的關係。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經科學用內視鏡設備市場：依產品類型分類

  • 軟式內視鏡
  • 硬式內視鏡
    • 可重複使用的
    • 一次性的
  • 影像內視鏡系統

第9章：神經科學用內視鏡設備市場：依技術分類

  • 螢光引導
  • 高清 4K 成像
  • 3D成像

第10章：神經科學用內視鏡設備市場：依應用領域分類

  • 清除腦室內出血
  • 腦下垂體腺瘤切除術
  • 第三心室手術

第11章神經科學用內視鏡設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：神經科學用內視鏡設備市場：依銷售管道分類

  • 直銷
  • 銷售代理
  • 線上銷售平台

第13章：神經科學用內視鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章神經科學用內視鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：神經科學用內視鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國神經科學用內視鏡設備市場

第17章：中國神經科學用內視鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ackermann Instrumente GmbH
  • adeor medical AG
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Clarus Medical LLC
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Schindler Endoskopie Technologie GmbH
  • Stryker Corporation
Product Code: MRR-036C5CF3B4C5

The Neurology Endoscopy Devices Market was valued at USD 272.41 million in 2025 and is projected to grow to USD 284.98 million in 2026, with a CAGR of 5.34%, reaching USD 392.13 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 272.41 million
Estimated Year [2026] USD 284.98 million
Forecast Year [2032] USD 392.13 million
CAGR (%) 5.34%

A concise introduction to how technological advances and clinical imperatives are reshaping neurosurgical endoscopy adoption across health systems

The neurology endoscopy device landscape has evolved into a technically sophisticated, clinically nuanced arena where precision tools intersect with minimally invasive care paradigms. Advances in imaging, ergonomic design, and single-use disposables are increasingly enabling neurosurgeons to perform complex intraventricular and skull base procedures with reduced operative morbidity. As a result, hospitals and specialty centers are recalibrating care pathways to incorporate endoscopic approaches for conditions that were once predominantly managed through open craniotomy.

Clinical drivers are converging with operational imperatives: shorter inpatient stays, faster recovery trajectories, and improved visualization during delicate resections are enhancing the value proposition of endoscopic systems. Concurrently, technological progress in high-definition four k imaging, three dimensional visualization, and fluorescence guidance is expanding the clinical envelope, enabling procedures such as intraventricular hemorrhage evacuation and pituitary adenoma resection to be undertaken in settings with rigorous safety protocols. These dynamics are influencing procurement behaviors and capital planning, prompting health systems to reassess both device portfolios and training investments.

Beyond clinical and operational drivers, industry stakeholders are responding to changing reimbursement frameworks and regulatory scrutiny that prioritize device safety, traceability, and sterilization workflows. This intersection of clinical efficacy, economic accountability, and regulatory compliance is shaping the way manufacturers design products, structure warranties, and support clinical training programs. As a consequence, stakeholders across the value chain-from ambulatory surgery centers to large hospital networks-are seeking integrated solutions that combine instrument performance with service, training, and evidence generation.

How cutting edge imaging modalities and disposable strategies are converging to redefine device design, clinical workflows, and site of care adoption

The landscape of neurology endoscopy is being redefined by a set of transformative shifts that span imaging capability, disposability strategies, and care-site decentralization. High-definition four k imaging and three dimensional visualization have elevated intraoperative decision making by providing surgeons with clearer anatomical context and depth perception, which in turn reduces reliance on ancillary exposures and adjunctive procedures. Fluorescence guidance is enabling more precise tumor margin delineation and vascular identification, thereby expanding the clinical indications amenable to endoscopic approaches.

Parallel to imaging innovations, device designers are addressing infection control and workflow efficiency through the development of single use rigid endoscope variants alongside reusable platforms. This bifurcation in product strategy is altering hospital sterilization protocols and capital replacement cycles, while also creating new procurement considerations related to disposable cost per procedure versus long-term instrument maintenance. Moreover, the increased capability of video endoscope systems to integrate with hospital information systems and cloud-enabled analytics is accelerating the digitalization of the operating room, enabling performance benchmarking and remote proctoring.

Another pivotal shift is the movement of select neurosurgical procedures into ambulatory settings and specialized clinics, driven by shorter anesthesia times and faster recoveries. This shift necessitates a rethinking of service models, including support for training, device servicing, and inventory management. Collectively, these technological and care-delivery shifts are not isolated; they interact to reshape clinical pathways, procurement strategies, and competitive positioning across manufacturers and service providers.

An authoritative assessment of how new import duty adjustments are reshaping sourcing strategies, pricing transparency, and operational continuity across the device value chain

The cumulative impact of United States tariff changes announced in 2025 has introduced a new layer of complexity into supply chains for neurology endoscopy devices and their componentry. Tariff adjustments affecting medical device components, precision optics, and certain electronic subsystems have compelled manufacturers to reassess their sourcing footprints, contractual terms with tier one suppliers, and cost allocation strategies. As import duties shift input costs, device producers are evaluating nearshoring and supplier diversification to protect margins without compromising quality or compliance.

Manufacturers with globalized production models are particularly susceptible to tariff volatility, as changes in cross-border duties can amplify unit production costs and complicate pricing negotiations with health systems that operate under constrained capital budgets. In response, procurement teams at hospitals and specialty clinics are increasingly asking suppliers for clear total cost of ownership analyses that incorporate tariff-driven cost impacts, freight variability, and potential lead-time implications. This heightened scrutiny is prompting suppliers to be more transparent about their supply chain resilience measures, including inventory buffering, dual-sourcing arrangements, and alternative logistic pathways.

Furthermore, the tariff landscape has influenced strategic decisions regarding product configuration and packaging. Some manufacturers are redesigning kits to reduce the number of tariffable components crossing borders, while others are relocating final assembly to tariff-favored jurisdictions. These operational shifts are accompanied by implications for regulatory filings, quality assurance oversight, and service networks. For clinicians and administrators, the practical effect has been an increased emphasis on vendor stability and predictable supply commitments to avoid procedural disruptions and to maintain continuity of care.

Insightful segmentation perspectives that link device types, clinical indications, care settings, imaging technologies, and commercial channels to adoption drivers and operational choices

Segmentation analysis reveals nuanced performance dynamics across product type, application, end user, technology, and sales channel that are central to strategic planning. Within product type, the landscape encompasses flexible endoscopes, rigid endoscopes, and video endoscope systems; the rigid endoscope category further differentiates between reusable and single use variants, each presenting distinct clinical and operational tradeoffs. Flexible systems are being positioned for anatomically challenging corridors, while video endoscope systems serve as integrative hubs for advanced imaging modalities.

Application segmentation highlights clinical pathways such as intraventricular hemorrhage evacuation, pituitary adenoma resection, and third ventricle procedures, where device selection is guided by anatomical access, visualization requirements, and surgeon preference. Each indication has unique instrumentation demands and training curves, which in turn influence purchasing patterns and service needs. End user segmentation spans ambulatory surgery centers, hospitals, and specialty clinics, and the distribution of procedural volumes across these settings affects device configuration, purchasing contracts, and aftermarket service expectations.

Technology segmentation spotlights modalities including fluorescence guidance, high definition four k imaging, and three dimensional imaging. These technologies not only drive clinical capability but also determine systems integration requirements and capital expenditure profiles. Sales channel segmentation covers direct sales, distributor networks, and online sales platforms, each shaping the procurement experience, lead times, and support models. Taken together, these segmentation lenses provide a composite view of how product features, clinical indications, care settings, imaging technologies, and distribution routes jointly influence adoption dynamics and strategic priorities.

A comprehensive regional analysis describing how differentiated reimbursement, regulatory environments, and infrastructure maturity shape device adoption and commercialization pathways

Regional dynamics exert a powerful influence on adoption, regulatory pathways, and commercial models for neurology endoscopy devices. In the Americas, investment in advanced imaging and a concentration of high-volume tertiary centers support rapid adoption of integrated video endoscope systems and advanced visualization adjuncts. Reimbursement structures and institutional purchasing preferences in this region tend to favor solutions that demonstrate clear perioperative efficiency gains and improved patient throughput.

The Europe, Middle East & Africa region presents heterogeneity in regulatory harmonization, hospital procurement models, and infrastructure maturity. Western European centers often prioritize safety, sterilization workflows, and long-term service agreements, while some Middle Eastern and African healthcare systems are accelerating investments in tertiary neurosurgical capabilities, creating opportunities for modular systems that can adapt to diverse clinical settings. Cross-border regulatory considerations and regional distribution capabilities play a pivotal role in deployment strategies.

In the Asia-Pacific region, rapid expansion of specialty clinics and increasing procedural volumes are encouraging adoption of both reusable and single use rigid endoscopes, as well as portable video endoscope systems. Local manufacturing initiatives and regional supply chain evolution are contributing to competitive device pricing and faster time to market. Across regions, differences in training infrastructure, hospital accreditation standards, and clinical guideline adoption create distinct pathways for product entry and scale-up, shaping how manufacturers prioritize investments and tailor their commercial approaches.

Key corporate profiles and competitive behaviors revealing how incumbents and specialized innovators are advancing imaging integration, training programs, and channel strategies

Competitive dynamics within the neurology endoscopy device ecosystem are characterized by a mix of established surgical device manufacturers and agile specialized innovators. Large medical technology firms are leveraging scale to integrate imaging platforms with hospital IT systems, invest in training academies, and offer bundled service agreements that reduce administrative overhead for health systems. These incumbents typically emphasize broad product portfolios, comprehensive warranty structures, and global service footprints to support multi-site deployments.

Specialized firms and start-ups are differentiating through niche capabilities such as advanced fluorescence optics, compact four k imaging modules, and single use rigid endoscopes designed to streamline workflow and minimize cross-contamination risk. These players often pursue focused clinical evidence generation and close clinical partnerships to accelerate adoption in high-impact indications such as pituitary adenoma resections. Partnerships between imaging software providers and device manufacturers are becoming more common, enabling enhanced intraoperative guidance and post-procedure analytics.

Channel strategies also vary, with some companies favoring direct engagement to provide clinical education and procedural support, while others rely on distributor networks to expand geographic reach quickly. An increasing number of suppliers are experimenting with online platforms for consumables and accessory sales, improving replenishment cycles for ambulatory centers and specialty clinics. Across the competitive landscape, success is increasingly tied to the ability to demonstrate clinical outcomes, provide robust training, and maintain predictable service levels across geographies.

Actionable strategic priorities for manufacturers and providers to align technological investments, supply chain resilience, and clinical training with sustainable adoption

Industry leaders should prioritize a strategic agenda that aligns technology investment with clinical outcomes and supply chain resilience. First, prioritize investments in imaging platforms that enhance intraoperative decision making, particularly high definition four k systems and three dimensional visualization, while integrating fluorescence guidance where clinically appropriate to improve procedural precision. These technology choices should be paired with outcome-focused evidence generation that demonstrates tangible improvements in safety, efficiency, and patient recovery trajectories.

Second, develop flexible product portfolios that balance reusable instruments with single use rigid endoscopes to accommodate diverse hospital sterilization capabilities and infection control policies. This balanced approach mitigates supply disruptions and allows buyers to tailor device selection to procedural volume and capital constraints. Third, fortify supply chains through supplier diversification, nearshoring where feasible, and transparent cost structures that anticipate tariff and logistics volatility. Engaging early with procurement stakeholders to provide clear total cost perspectives will foster trust and reduce procurement friction.

Finally, invest in comprehensive clinical training and remote support capabilities to accelerate safe adoption across ambulatory surgery centers, hospitals, and specialty clinics. Training programs should include simulation, proctorship, and digital learning modules to shorten the learning curve. Combine these initiatives with flexible commercial models-such as outcome-based agreements and service bundles-that align incentives with healthcare providers and enhance long-term partnerships.

A transparent research approach combining clinician interviews, technical synthesis, and data triangulation to produce reproducible insights on device performance and adoption drivers

The research methodology for this analysis combined structured primary inquiry with rigorous secondary synthesis and multi-point data validation to ensure balanced, evidence-driven conclusions. Primary research consisted of in-depth interviews with practicing neurosurgeons, OR managers, procurement leads, and service technicians to surface real-world device performance considerations, procedural workflows, and adoption barriers. These stakeholder conversations provided qualitative insights into clinical preferences, sterilization practices, and support expectations across different care settings.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance documents, product technical specifications, and publicly available policy announcements to contextualize clinical efficacy, safety considerations, and regulatory trends. Data triangulation methods were employed to reconcile differences between anecdotal feedback and published evidence, ensuring that conclusions reflect convergent signals rather than isolated observations. Where appropriate, case studies were used to illustrate successful deploy-ment models and to highlight how technology choices translated into operational improvements.

Analytical steps included thematic coding of interview transcripts, comparative assessments of technology capabilities, and scenario analysis to evaluate the implications of tariff shifts and supply chain changes. Quality assurance protocols included cross-review by clinical and commercial subject matter experts to validate assertions and to minimize bias. The methodology emphasizes transparency and reproducibility, providing a robust foundation for the recommendations and insights presented herein.

A conclusive synthesis highlighting how imaging advances, disposable strategies, and supply chain resilience will determine adoption trajectories and clinical outcomes

In summary, the neurology endoscopy device ecosystem is entering a phase marked by accelerated imaging innovation, nuanced disposable strategies, and emergent supply chain complexity. Technology enhancements such as high definition four k imaging, three dimensional visualization, and fluorescence guidance are expanding surgical capabilities and enabling less invasive approaches for complex intracranial conditions. At the same time, the coexistence of reusable and single use rigid endoscopes introduces operational choices that health systems must reconcile with sterilization practices and capital planning.

External factors, including tariff adjustments and regional regulatory heterogeneity, are influencing sourcing decisions and commercial approaches. Manufacturers and providers that proactively address supply chain resilience, align product portfolios to clinical workflows, and invest in outcome-driven evidence and training will be best positioned to realize clinical and operational value. The path to wider adoption will be paved by collaborative partnerships that link device innovation with pragmatic service models, ensuring that technological advances translate into improved patient outcomes and sustainable care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Endoscopy Devices Market, by Product Type

  • 8.1. Flexible Endoscope
  • 8.2. Rigid Endoscope
    • 8.2.1. Reusable
    • 8.2.2. Single Use
  • 8.3. Video Endoscope System

9. Neurology Endoscopy Devices Market, by Technology

  • 9.1. Fluorescence Guidance
  • 9.2. High Definition Four K Imaging
  • 9.3. Three D Imaging

10. Neurology Endoscopy Devices Market, by Application

  • 10.1. Intraventricular Hemorrhage Evacuation
  • 10.2. Pituitary Adenoma Resection
  • 10.3. Third Ventricle Procedure

11. Neurology Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgery Center
  • 11.2. Hospital
  • 11.3. Specialty Clinic

12. Neurology Endoscopy Devices Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributor
  • 12.3. Online Sales Platform

13. Neurology Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neurology Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurology Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Neurology Endoscopy Devices Market

17. China Neurology Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ackermann Instrumente GmbH
  • 18.6. adeor medical AG
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Clarus Medical LLC
  • 18.10. Fujifilm Holdings Corporation
  • 18.11. HOYA Corporation
  • 18.12. Integra LifeSciences Holdings Corporation
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Medtronic plc
  • 18.16. Olympus Corporation
  • 18.17. Richard Wolf GmbH
  • 18.18. Schindler Endoskopie Technologie GmbH
  • 18.19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)